IBDEI1IS ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26982,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26982,1,2,0)
 ;;=2^Chemodenerv Musc Neck Dyston
 ;;^UTILITY(U,$J,358.3,26982,1,3,0)
 ;;=3^64616
 ;;^UTILITY(U,$J,358.3,26983,0)
 ;;=64642^^159^1744^1^^^^1
 ;;^UTILITY(U,$J,358.3,26983,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26983,1,2,0)
 ;;=2^Chemodenerv 1 Extremity 1-4
 ;;^UTILITY(U,$J,358.3,26983,1,3,0)
 ;;=3^64642
 ;;^UTILITY(U,$J,358.3,26984,0)
 ;;=64643^^159^1744^2^^^^1
 ;;^UTILITY(U,$J,358.3,26984,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26984,1,2,0)
 ;;=2^Chemodenerv 1 Extremity 1-4 Ea
 ;;^UTILITY(U,$J,358.3,26984,1,3,0)
 ;;=3^64643
 ;;^UTILITY(U,$J,358.3,26985,0)
 ;;=64644^^159^1744^3^^^^1
 ;;^UTILITY(U,$J,358.3,26985,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26985,1,2,0)
 ;;=2^Chemodenerv 1 Extremity 5/> Mus
 ;;^UTILITY(U,$J,358.3,26985,1,3,0)
 ;;=3^64644
 ;;^UTILITY(U,$J,358.3,26986,0)
 ;;=64645^^159^1744^4^^^^1
 ;;^UTILITY(U,$J,358.3,26986,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26986,1,2,0)
 ;;=2^Chemodenerv 1 Extremity 5/> Ea
 ;;^UTILITY(U,$J,358.3,26986,1,3,0)
 ;;=3^64645
 ;;^UTILITY(U,$J,358.3,26987,0)
 ;;=64646^^159^1744^7^^^^1
 ;;^UTILITY(U,$J,358.3,26987,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26987,1,2,0)
 ;;=2^Chemodenerv Trunk Musc 1-5
 ;;^UTILITY(U,$J,358.3,26987,1,3,0)
 ;;=3^64646
 ;;^UTILITY(U,$J,358.3,26988,0)
 ;;=64647^^159^1744^8^^^^1
 ;;^UTILITY(U,$J,358.3,26988,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26988,1,2,0)
 ;;=2^Chemodenerv Trunk Musc 6/>
 ;;^UTILITY(U,$J,358.3,26988,1,3,0)
 ;;=3^64647
 ;;^UTILITY(U,$J,358.3,26989,0)
 ;;=J0585^^159^1744^9^^^^1
 ;;^UTILITY(U,$J,358.3,26989,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26989,1,2,0)
 ;;=2^OnabotulinumtoxinA 1 Unit
 ;;^UTILITY(U,$J,358.3,26989,1,3,0)
 ;;=3^J0585
 ;;^UTILITY(U,$J,358.3,26990,0)
 ;;=J0587^^159^1744^10^^^^1
 ;;^UTILITY(U,$J,358.3,26990,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26990,1,2,0)
 ;;=2^RimabotulinumtoxinB 100 Units
 ;;^UTILITY(U,$J,358.3,26990,1,3,0)
 ;;=3^J0587
 ;;^UTILITY(U,$J,358.3,26991,0)
 ;;=98925^^159^1745^1^^^^1
 ;;^UTILITY(U,$J,358.3,26991,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26991,1,2,0)
 ;;=2^OMT,1-2 Body Regions
 ;;^UTILITY(U,$J,358.3,26991,1,3,0)
 ;;=3^98925
 ;;^UTILITY(U,$J,358.3,26992,0)
 ;;=98926^^159^1745^2^^^^1
 ;;^UTILITY(U,$J,358.3,26992,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26992,1,2,0)
 ;;=2^OMT,3-4 Body Regions
 ;;^UTILITY(U,$J,358.3,26992,1,3,0)
 ;;=3^98926
 ;;^UTILITY(U,$J,358.3,26993,0)
 ;;=98927^^159^1745^3^^^^1
 ;;^UTILITY(U,$J,358.3,26993,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26993,1,2,0)
 ;;=2^OMT,5-6 Body Regions
 ;;^UTILITY(U,$J,358.3,26993,1,3,0)
 ;;=3^98927
 ;;^UTILITY(U,$J,358.3,26994,0)
 ;;=98928^^159^1745^4^^^^1
 ;;^UTILITY(U,$J,358.3,26994,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26994,1,2,0)
 ;;=2^OMT,7-8 Body Regions
 ;;^UTILITY(U,$J,358.3,26994,1,3,0)
 ;;=3^98928
 ;;^UTILITY(U,$J,358.3,26995,0)
 ;;=98929^^159^1745^5^^^^1
 ;;^UTILITY(U,$J,358.3,26995,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26995,1,2,0)
 ;;=2^OMT,9-10 Body Regions
 ;;^UTILITY(U,$J,358.3,26995,1,3,0)
 ;;=3^98929
 ;;^UTILITY(U,$J,358.3,26996,0)
 ;;=97762^^159^1746^1^^^^1
 ;;^UTILITY(U,$J,358.3,26996,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26996,1,2,0)
 ;;=2^C/O for Orthotic/Prosth Use
 ;;^UTILITY(U,$J,358.3,26996,1,3,0)
 ;;=3^97762
 ;;^UTILITY(U,$J,358.3,26997,0)
 ;;=96116^^159^1746^2^^^^1
 ;;^UTILITY(U,$J,358.3,26997,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26997,1,2,0)
 ;;=2^Neurobehavioral Status Exam,per hour
 ;;^UTILITY(U,$J,358.3,26997,1,3,0)
 ;;=3^96116
 ;;
 ;;$END ROU IBDEI1IS
